Phenotypic Displays of Cholinergic Enzymes Associate With Markers of Inflammation, Neurofibrillary Tangles, and Neurodegeneration in Pre- and Early Symptomatic Dementia Subjects

BACKGROUND: Cholinergic drugs are the most commonly used drugs for the treatment of Alzheimer’s disease (AD). Therefore, a better understanding of the cholinergic system and its relation to both AD-related biomarkers and cognitive functions is of high importance. OBJECTIVES: To evaluate the relation...

Descripción completa

Detalles Bibliográficos
Autores principales: Teitsdottir, Unnur D., Darreh-Shori, Taher, Lund, Sigrun H., Jonsdottir, Maria K., Snaedal, Jon, Petersen, Petur H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Aging Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178195/
https://www.ncbi.nlm.nih.gov/pubmed/35693340
http://dx.doi.org/10.3389/fnagi.2022.876019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178195/
https://www.ncbi.nlm.nih.gov/pubmed/35693340
http://dx.doi.org/10.3389/fnagi.2022.876019

Ejemplares similares